A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma

NCT00201396 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

480

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

RADIATION: CCRT
DRUG: Mitomycin C,Epirubicin,Cisplatin,5-Fluorouracil,Leucovorin

Sponsor

National Health Research Institutes, Taiwan

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]